4//SEC Filing
Travis David L 4
Accession 0001127602-24-023013
CIK 0000877860other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:08 PM ET
Size
37.0 KB
Accession
0001127602-24-023013
Insider Transaction Report
Form 4
Travis David L
SVP/Chief Accounting Officer
Transactions
- Exercise/Conversion
Stock Option (Right to buy) 2022
2024-08-23−11,666→ 0 totalExercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (11,666 underlying) - Exercise/Conversion
Common Stock
2024-08-23$53.76/sh+2,500$134,400→ 12,000 total - Tax Payment
Common Stock
2024-08-23$78.63/sh−22,839$1,795,831→ 14,461 total - Exercise/Conversion
Stock Options - 2020
2024-08-23−2,500→ 0 totalExercise: $53.76From: 2022-05-01Exp: 2025-05-01→ Common Stock (2,500 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-08-23−9,262→ 2,404 totalExercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (9,262 underlying) - Exercise/Conversion
Common Stock
2024-08-23$53.41/sh+9,262$494,683→ 35,428 total - Exercise/Conversion
Stock Options - 2020
2024-08-23−2,500→ 0 totalExercise: $53.76From: 2020-05-01Exp: 2025-05-01→ Common Stock (2,500 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-08-23−1,872→ 9,796 totalExercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (1,872 underlying) - Exercise/Conversion
Common Stock
2024-08-23$53.76/sh+2,500$134,400→ 9,500 total - Exercise/Conversion
Common Stock
2024-08-23$53.41/sh+1,872$99,984→ 37,300 total - Exercise/Conversion
Stock Options - 2020
2024-08-23−2,500→ 0 totalExercise: $53.76From: 2021-05-01Exp: 2025-05-01→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2024-08-23$53.76/sh+2,500$134,400→ 14,500 total - Exercise/Conversion
Common Stock
2024-08-23$53.41/sh+11,666$623,081→ 26,166 total
Holdings
- 11,666
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (11,666 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 11,666
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (11,666 underlying) - 11,668
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (11,668 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-28→ Common Stock (8,334 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying)
Footnotes (1)
- [F1]Acquired due to the net exercise of stock options granted 5/1/2020 and 2/25/22 with shares withheld by the Company to cover the exercise price and taxes. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Entity typeother
Related Parties
1- filerCIK 0001685397
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:08 PM ET
- Size
- 37.0 KB